Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 26, 2026

Top Research Reports for Meta, Netflix & Pfizer

View original at finance.yahoo.com
Top Research Reports for Meta, Netflix & Pfizer Thursday, February 26, 2026 The Zacks Research Daily presents the best research output of our analyst team…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Pfizer expects its recently launched and acquired products and a strong pipeline to help revive top-line growth toward the end of the decade

    80% confidence
  • Flowers Foods fourth quarter total company volume declined 2.2%

    80% confidence
  • Netflix has about two hours of viewing per member per day

    80% confidence
  • Altigen's top five accounts represented 83% of sales

    80% confidence
  • Recommendation improvement drove 20% lift in time spent on Threads

    80% confidence
  • Instagram Reels had a strong fourth-quarter, with watch time up more than 30% year-over-year in the United States

    80% confidence
  • Facebook video time continued to grow double-digits year-over-year in the United States

    80% confidence
  • Meta Platforms now expects to invest significantly more over the next few years in developing more advanced models and the largest AI services in the world

    80% confidence
  • Meta's improved recommendation system is driving up user engagement

    80% confidence
  • 2026 guidance projects revenue growth of 12-14% for Netflix

    80% confidence
  • Monetization of AI services will take considerable time

    80% confidence
  • Netflix has set an ambitious target to double its revenues by 2030 and reach a $1 trillion market capitalization

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com